Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,291 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $316.28 | 4 | $0 (2020) |
| PORTOLA PHARMACEUTICALS, LLC | $152.64 | 2 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $131.82 | 3 | $0 (2020) |
| Valeant Pharmaceuticals North America LLC | $111.89 | 2 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $102.25 | 1 | $0 (2019) |
| The Medicines Company | $93.74 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $92.63 | 1 | $0 (2018) |
| Philips Electronics North America Corporation | $79.49 | 1 | $0 (2018) |
| Chiesi USA, Inc. | $60.39 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $58.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $99.77 | 4 | E.R. Squibb & Sons, L.L.C. ($52.06) |
| 2019 | $596.29 | 7 | PORTOLA PHARMACEUTICALS, INC. ($130.81) |
| 2018 | $232.51 | 3 | Melinta Therapeutics, Inc. ($92.63) |
| 2017 | $362.17 | 5 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/24/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/31/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2020 | PORTOLA PHARMACEUTICALS, LLC | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/13/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $52.06 | General |
| Category: Cardiovascular | ||||||
| 11/14/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $47.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/11/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $107.68 | General |
| Category: Cardiovascular | ||||||
| 04/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $58.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/13/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $130.81 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 01/10/2019 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $43.13 | General |
| Category: GIAPREZA | ||||||
| 09/13/2018 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $60.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/12/2018 | Melinta Therapeutics, Inc. | Orbactiv (Drug) | Food and Beverage | Cash or cash equivalent | $92.63 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $79.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 793 | 828 | $985,689 | $71,853 |
| 2022 | 5 | 772 | 815 | $881,718 | $64,122 |
| 2021 | 6 | 1,081 | 1,168 | $1.3M | $98,077 |
| 2020 | 5 | 658 | 687 | $1.1M | $83,322 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 368 | 386 | $707,689 | $51,107 | 7.2% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 150 | 154 | $187,378 | $13,893 | 7.4% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 57 | 57 | $41,967 | $3,130 | 7.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 15 | 15 | $32,425 | $2,418 | 7.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 203 | 216 | $16,230 | $1,306 | 8.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 284 | 297 | $572,168 | $41,137 | 7.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 105 | 110 | $139,205 | $10,019 | 7.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 40 | 42 | $91,845 | $7,212 | 7.9% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 74 | 74 | $57,038 | $3,918 | 6.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 269 | 292 | $21,462 | $1,835 | 8.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 357 | 391 | $767,338 | $54,425 | 7.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 106 | 111 | $243,756 | $20,153 | 8.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 157 | 162 | $208,326 | $15,105 | 7.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 75 | 76 | $61,540 | $4,158 | 6.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 370 | 409 | $29,050 | $2,564 | 8.8% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 16 | 19 | $19,134 | $1,673 | 8.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 291 | 312 | $613,241 | $43,831 | 7.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 115 | 118 | $251,282 | $22,067 | 8.8% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 133 | 138 | $178,236 | $12,982 | 7.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 89 | 89 | $66,124 | $4,267 | 6.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 30 | 30 | $1,798 | $175.52 | 9.8% |
About Dr. Brian Baker, D.O
Dr. Brian Baker, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1922459015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Baker, D.O has received a total of $1,291 in payments from pharmaceutical and medical device companies, with $99.77 received in 2020. These payments were reported across 19 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($1,291).
As a Medicare-enrolled provider, Baker has provided services to 3,304 Medicare beneficiaries, totaling 3,498 services with total Medicare billing of $317,374. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 06/29/2016
- Last Updated 06/29/2016
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1922459015
Products in Payments
- ELIQUIS (Drug) $364.03
- ANDEXXA (Biological) $152.64
- LOKELMA (Drug) $131.82
- XIFAXAN (Drug) $111.89
- RELISTOR (Drug) $102.25
- MINOCIN IV (Drug) $93.74
- Orbactiv (Drug) $92.63
- IGT_D Peripheral (Device) $79.49
- CLEVIPREX (Drug) $60.39
- XARELTO (Drug) $58.73
- GIAPREZA (Drug) $43.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117